Product Directory — Diagnostics, Devices & Equipment


Refine by Category
Refine by Company

Showing Products For: Flu Tests

Select Page
OSOM® Ultra Plus Flu A&B Test SEKISUI DIAGNOSTICS
The OSOM® Ultra Plus Flu A & B Test by Sekisui is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab and nasopharyngeal swab specimens obtained from patients with signs and symptoms of respiratory infection.


OSOM® Ultra Plus Flu A&B Test

Stronger Clinical Performance Takes Lateral Flow Testing To The Next Level

Providing superior rapid results at the point-of-care. Fast, easy, cost effective so you can test and treat in one visit.

  • High Performance
    • Equivalent to or exceeding the performance of reader devices, without the need for an instrument
  • Results in 10 minutes
  • Exceptional Support/Training by licensed medical technologists and experienced healthcare professionals
  • Made in the USA
  • Award-winning supply chain capabilities
  • Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples


The OSOM®Ultra Plus Flu A & B Test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab and nasopharyngeal swab specimens obtained from patients with signs and symptoms of respiratory infection.


*Refer to the Package Insert for additional performance claims.

SEKISUI DIAGNOSTICS 4 Hartwell Place | | Lexington | MA | For over 35 years Sekisui Diagnostics has been committed to providing innovative medical diagnostics to physicians and laboratories. We develop, manufacture, and supply billions of tests each year to the global healthcare market. Our product lines include clinical chemistry and coagulation systems and reagents, point-of-care molecular, rapid tests and immunoassay system as well as enzymes and specialty biochemicals.
BD Veritor System BD Diagnostics
BD - Diagnostic Systems: BD Veritor System: CLIA-waived For Rapid Detection of Flu A+B.


BD




BD Veritor ™ System
CLIA-waived for Rapid Detection of Flu A+B meets the New FDA Requirements

Our BD Veritor ™ line of immunoassay products, the BD Veritor ™ Plus System and the BD Veritor ™ System give healthcare providers and laboratorians in near patient settings the objective, lab-quality tests results at the point of care within minutes. This assay system eliminates the subjectivity of visual interpretations of tests results and replaces it with an objective digital result.

BD Veritor ™ System – Proven Performance vs. Polymerase Chain Reaction (PCR)
  • PCR is currently the highest sensitivity standard available


Summary of the Performance Data for the BD Veritor System for Rapid Detection of Flu A+B tests compared to PCR for all swabs – all sites

BD



Convenient Workflow

BD


Changing The Way You View Rapid Testing

BD


BD Diagnostics 7 Loveton Circle | | Sparks | MD | BD - Diagnostic Systems: BD Veritor System: CLIA-waived For Rapid Detection of Flu A+B
cobas® Influenza A/B assay ROCHE DIAGNOSTICS
The cobas Influenza A/B assay is the first CLIA-waived, real-time PCR test to detect Influenza A and B in ~20 minutes


cobas® Influenza A/B assay

The cobas® Influenza A/B assay is the first CLIA-waived, real-time PCR test to detect Influenza A and B in ~20 minutes. Available for use in non-traditional testing sites, including ERs, physician offices, pharmacy clinics and other urgent care settings.

Benefits:
  • Lab-quality performance in the detection and differentiation of Influenza A and Influenza B
  • Fast results—20-min. turnaround time
  • Simplicity—minimal hands-on time, walk-away test with easy results interpretation
  • Supports timely, confident treatment decisions


ROCHE DIAGNOSTICS 9115 Hague Road | Bldg. H | Indianapolis | IN | Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways
cobas® Influenza A/B & RSV assay ROCHE DIAGNOSTICS
The cobas Influenza A/B & RSV assay is the first CLIA-waived, real-time PCR test that differentiates Influenza A, Influenza B and RSV in 20 minutes


cobas® Influenza A/B & RSV assay

The cobas Influenza A/B & RSV assay is the first CLIA-waived, real-time PCR test that differentiates Influenza A, Influenza B and RSV in 20 minutes. It's available for use in hospitals, physician offices and urgent care settings.

Benefits:
  • Lab-quality performance in the detection and differentiation of Influenza A, Influenza B and RSV strains
  • Fast results, 20-min. turnaround time
  • Simplicity—minimal hands-on time, walkaway test with easy results interpretation
  • Supports timely, confident treatment decisions


ROCHE DIAGNOSTICS 9115 Hague Road | Bldg. H | Indianapolis | IN | Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways
BioFire FilmArray® Torch BioFire Diagnostics
The BioFire® FilmArray® Torch is a fully integrated, random, and continuous access system designed to meet your laboratory’s syndromic infectious disease testing needs


The BioFire® FilmArray® Torch is a fully integrated, random, and continuous access system designed to meet your laboratory's syndromic infectious disease testing needs. The BioFire Torch offers a radically reduced benchtop footprint, saving precious space in the lab, and its scalability meets high throughput demands. BioFire® FilmArray® Link Software automatically uploads patient results. Fully compatible with all CLIA Moderate BioFire® FilmArray® Panels, the BioFire Torch helps you maximize efficiency and productivity.

BioFire Diagnostics 515 Colorow Dr | | Salt Lake City | UT | BioFire simplifies our customers’ lives by innovating easy-to-use clinical molecular diagnostic solutions that provide fast and accurate results.